Drugs Health Pharma

USFDA postpones Organon’s eczema drug review by three months

The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.

Read More
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More